Browsing by Author Syed, Adil

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2016Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy OutcomesChang, Andrew; Schlub, Timothy; Zhu, Meidong; Broadhead, Geoffrey K; Hong, Thomas; Joachim, Nichole; Peto, Tunde; Syed, Adil; Toth, L; Northern Clinical School: Clinical Ophthal & Eye Health; Central Clinical School: Medicine; Central Clinical School: Save Sight & Eye Health Inst.Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes, Ophthalmic research, vol.55, 2, 2016,pp 84-90
2015Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomesBroadhead, Geoffrey; Chang, Andrew; Chew, Jamie Kok Wai; Syed, Adil; Zhu, Meidong; Hong, Thomas; Joachim, Nichole; Luo, Kehui; Central Clinical School: Save Sight & Eye Health Inst.; Northern Clinical School: Clinical Ophthal & Eye Health; Central Clinical School: Ophthalmology & Eye Health; Medicine; Central Clinical School: Save Sight & Eye Health Inst.Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes, Graefes Archive for Clinical and Experimental Ophthalmology, vol.253, 8, 2015,pp 1217-1225
2017Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degenerationBroadhead, Geoffrey; Chang, Andrew; Syed, Adil; Wijeyakumar, Wijeyanthy; Zhu, Meidong; Hong, Thomas; Joachim, Nichole; Li, Haitao; Luo, Kehui; Central Clinical School: Save Sight & Eye Health Inst.; Northern Clinical School: Clinical Ophthal & Eye Health; Medicine; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration, Graefes Archive for Clinical and Experimental Ophthalmology, vol.255, 3, 2017,pp 475-484